Targeted ablative therapies for prostate cancer
Men diagnosed with low-to intermediate-risk, clinically localized prostate cancer (PCa) often
face a daunting and difficult decision with respect to treatment: active surveillance (AS) or …
face a daunting and difficult decision with respect to treatment: active surveillance (AS) or …
Magnetic Resonance Image–Guided Focal Prostate Ablation
SG Nour - Seminars in interventional radiology, 2016 - thieme-connect.com
Prostate cancer is the most common cancer (other than skin cancer) in American men, with
one in seven men being diagnosed with this disease during his lifetime. The estimated …
one in seven men being diagnosed with this disease during his lifetime. The estimated …
Focal therapy for prostate cancer. Alternative treatment
F Gómez-Veiga, S Martínez-Breijo… - Actas Urológicas …, 2014 - Elsevier
Context The great controversy surrounding the treatment of localized prostate cancer is
related with its possibilities of radical treatment or active surveillance. The objective of this …
related with its possibilities of radical treatment or active surveillance. The objective of this …
[HTML][HTML] Quantifying post-laser ablation prostate therapy changes on MRI via a domain-specific biomechanical model: preliminary findings
R Toth, D Sperling, A Madabhushi - Plos one, 2016 - journals.plos.org
Focal laser ablation destroys cancerous cells via thermal destruction of tissue by a laser.
Heat is absorbed, causing thermal necrosis of the target region. It combines the aggressive …
Heat is absorbed, causing thermal necrosis of the target region. It combines the aggressive …
Transrectal laser focal therapy of prostate cancer
JF Feller, BM Greenwood, RJ Stafford - Imaging and focal therapy of early …, 2017 - Springer
Laser focal therapy (LFT) is an evolving ablative technique for the treatment of prostate
cancer. Also referred to as laser interstitial thermal therapy (LITT) or focal laser ablation …
cancer. Also referred to as laser interstitial thermal therapy (LITT) or focal laser ablation …
T2*-weighted MRI as a non-contrast-enhanced method for assessment of focal laser ablation zone extent in prostate cancer thermotherapy
C Sun, S Wang, A Chatterjee, M Medved, S Eggener… - European …, 2021 - Springer
Objectives To evaluate utility of T2*-weighted (T2* W) MRI as a tool for intra-operative
identification of ablation zone extent during focal laser ablation (FLA) of prostate cancer …
identification of ablation zone extent during focal laser ablation (FLA) of prostate cancer …
Pre-clinical validation of transrectal diffuse optical tomography for monitoring photocoagulation progression during photothermal therapy of prostate cancer
CL Li, CJ Fisher, RB Shi, BC Wilson… - Multimodal …, 2019 - spiedigitallibrary.org
Diffuse optical tomography in a transrectal configuration (TR-DOT) has been developed to
monitor progression of the photocoagulation front during interstitial photothermal therapy …
monitor progression of the photocoagulation front during interstitial photothermal therapy …
Robot for magnetic resonance imaging guided focal prostate laser ablation
A Squires, S Xu, R Seifabadi… - Journal of …, 2016 - asmedigitalcollection.asme.org
Background Approximately, 240,000 men in the US are diagnosed with prostate cancer
annually [1]. The majority of these cases represent low-risk, organ-confined disease for …
annually [1]. The majority of these cases represent low-risk, organ-confined disease for …
Initial experience of targeted focal interstitial laser ablation of prostate cancer with MRI guidance
A Barqawi, K Krughoff, H Li, NU Patel - Current Urology, 2015 - karger.com
Introduction: To develop and evaluate a technique of 3.0 Tesla magnetic resonance (MR)
guided laser ablation based on 3-dimentional mapping biopsy (3DMB) for low risk prostate …
guided laser ablation based on 3-dimentional mapping biopsy (3DMB) for low risk prostate …
MR Imaging–Guided Focal Treatment of Prostate Cancer: An Update
SG Nour - Radiologic Clinics, 2018 - radiologic.theclinics.com
Minimally invasive targeted therapy has steadily developed into an integral part of cancer
treatment paradigms over the last 2 decades. The urologic oncology community has …
treatment paradigms over the last 2 decades. The urologic oncology community has …